Brind.

The FDA cleared the PreClara Ratio biomarker test, which Trinity Biotech is rolling out a service for in the US.

1 report, 1 independent Updated Aug 7

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA RATIO

Keep exploring

The entities involved

FDA
- Granules India Limited is submitting ANDA and Paragraph IV certification to the FDA.03:54
- NRx Pharmaceuticals is undergoing a first-cycle review of an ANDA for ketamine, noting its strategic importance for the U.S. military and VA.Sun 19:54
RATIO
company

Nothing else this week.

Related events

FDA granted 510(k) clearance for combined technologies for Solventum.Oct 19
FDA approval is the goal for product candidates from Daré Bioscience, Inc.Jun 7

Coverage

Newest first; wire copies grouped

Aug 7GlobeNewswireTrinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service FDA-cleared PreClara™ Ratio (sFlt-1/PlGF) biomarker test offers clinicians a crucial tool for managing hypertensive disord